NASH limits anti-tumour surveillance in immunotherapy-treated HCC | Nature
Llovet Bayer, Josep M – ICREA Memoir 2017
Low incidence of hepatocellular carcinoma in mice and cats treated with systemic adeno-associated viral vectors: Molecular Therapy - Methods & Clinical Development
Frontiers | Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies
Josep Maria Llovet - Revista Mètode
Juan Llovet de Casso - Cloud Solution Architect - Microsoft | LinkedIn
Juan Llovet de Casso - Cloud Solution Architect - Microsoft | LinkedIn
Negative phase 3 study of 90Y microspheres versus sorafenib in HCC
MARIA LLOVETS EROS PSYCHE #2 CVR A ADAM GORHAM (MR) – Black Cape Comics
Updates to Adjuvant and Neoadjuvant Therapy in Early HCC
GI Joe #300, IDW's Last GI Joe Comic in IDW's November 2022 Solicits
Dr. Llovet on Considering Safety Profiles During Treatment Selection in HCC
MARIA LLOVETS EROS PSYCHE #1 CVR B MARIA LLOVET (MR) – Black Cape Comics
MARIA LLOVETS EROS PSYCHE #1 10 COPY MERCADO VIRGIN INCV (MR – Black Cape Comics
Expanded Treatment Efficacy and Safety Study of Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcino
Correction of Secondary Fluorescence Across Phase Boundaries in Electron Probe Microanalysis of Mineral Inclusions | Microscopy and Microanalysis | Cambridge Core